US Bancorp
CABA icon

US Bancorp’s Cabaletta Bio CABA Stock Holding History

US Bancorp’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-191
Closed -$902 – 4170
2024
Q3 		$902 Sell
191
-226
-54% -$1.31K ﹤0.01% 3903
2024
Q2 		$3.12K Buy
417
+143
+52% +$1.75K ﹤0.01% 3623
2024
Q1 		$4.67K Hold
274
– – ﹤0.01% 3541
2023
Q4 		$6.22K Buy
+274
New +$4.61K ﹤0.01% 3459
2021
Q4 		– Sell
-900
Closed -$11K – 4104
2021
Q3 		$11K Hold
900
– – ﹤0.01% 3392
2021
Q2 		$8K Hold
900
– – ﹤0.01% 3471
2021
Q1 		$10K Hold
900
– – ﹤0.01% 3276
2020
Q4 		$11K Hold
900
– – ﹤0.01% 3136
2020
Q3 		$10K Buy
900
+600
+200% +$6.9K ﹤0.01% 3069
2020
Q2 		$3K Buy
+300
New +$2.3K ﹤0.01% 3419

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

US Bancorp's CABA Position: Q4 2024 in Review

US Bancorp sold out of Cabaletta Bio (CABA) in Q4 2024, closing a stake of 191 shares — an estimated $902 sold.

US Bancorp first reported a position in CABA in Q2 2020 and held it in 10 quarters. The position peaked at $11K in Q3 2021. 108 funds tracked by Wall St. Rank hold CABA as of Q4 2024.

  • US Bancorp reported no remaining Cabaletta Bio position as of Q4 2024 after selling out during the quarter.
  • US Bancorp sold 191 Cabaletta Bio shares in Q4 2024, an estimated $902.
  • US Bancorp first reported a position in Cabaletta Bio in Q2 2020 and held it in 10 quarters.
  • US Bancorp's Cabaletta Bio position peaked at $11K in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q4 2024.

Based on US Bancorp's 13F filing for Q4 2024, filed 5 Feb 2025.